SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Chow PKH; Gandhi M; Tan SB; Khin MW; Khasbazar A; Ong J; Choo SP; Cheow PC; Chotipanich C; Lim K

doi:10.1200/jco.2017.76.0892

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Identifier:nobleid.org/w1/20260526/AC695AC2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC695AC2.svg?ark=w1%2F20260526%2FAC695AC2)](https://nobleid.org/work/w1/20260526/AC695AC2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Identifier:nobleid.org/w1/20260526/AC695AC2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC695AC2.svg?ark=w1%2F20260526%2FAC695AC2)](https://nobleid.org/work/w1/20260526/AC695AC2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work